GlobeStar Therapeutics Corporation
GSTC · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $907 | $1,127 | $904 | $1,692 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $329 | $336 | $375 | $366 |
| Enterprise Value | $1,236 | $1,463 | $1,279 | $2,058 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$168 | -$156 | -$288 |
| % Margin | – | – | – | – |
| Net Income | -$198 | -$175 | -$164 | -$351 |
| % Margin | – | – | – | – |
| EPS Diluted | -0 | -0 | -0 | -0 |
| % Growth | 0% | 0% | 50% | – |
| Operating Cash Flow | -$20 | -$12 | -$43 | -$73 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$20 | -$12 | -$43 | -$73 |